Dainippon Sumitomo taps the potential of iPS cells for rare disease research
26 April 2011
Ian Haydock
Please Login to read the full article.
26 April 2011
Ian Haydock
ian.haydock@informa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- New US patent firms up ground for commercial use of Kyoto's iPS stem cells
- US grants iPS cell patent to Japanese university pioneer
- New iPierian development programmes focus on tau protein and complement pathway
- DSP's Boston acquisition in line with Japanese pharma's shift to oncology
ANALYSIS
Other Informa Analysis
COMMENT
Other Informa Comment
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
